Applied dna reports first quarter fiscal 2025 financial results and highlights operational progress

- announces exit of dna tagging and security products and services business segment - - workforce reduction of 20% of headcount implemented in january - - gmp site 1 facility complete and certified for commercial operation in january - - webcast and conference call scheduled for today at 4:30 pm et - stony brook, ny / access newswire / february 13, 2025 / applied dna sciences, inc. (nasdaq:apdn) ("applied dna" or the "company"), a leader in pcr-based dna technologies, today reported financial results for its first quarter of fiscal 2025 ended december 31, 2024. the company's form 10-q, once filed, can be viewed on the sec filings page of its investor relations website.
APDN Ratings Summary
APDN Quant Ranking